You are viewing an incomplete version of our website. Please click to reload the website as full version.


Details for Product No. ABIN412149, Supplier: Login to see New
Request Want additional data for this product?

The Independent Validation Initiative strives to provide you with high quality data. Find out more

Cell Culture (CC), Functional Studies (Func)
Pubmed 5 references available
Supplier Login to see New
Catalog number from supplier Login to see New
Quantity 1 g
Shipping to United States ( )
Availability Will be delivered in 2 to 3 Business Days
Characteristics Celecoxib is a highly selective COX-2 inhibitor and primarily inhibits prostaglandin production. Celecoxib is approximately 7.6-fold more selective for COX-2 inhibition over COX-1.This specificity allows celecoxib to reduce inflammation and pain while minimizing gastrointestinal adverse drug reactions that are common with non-selective non-steroidal anti-inflammatory drugs.
Purity 99,00 %
Molecular Weight 381.37 Da
CAS-No 169590-42-5
Restrictions For Research Use only
Format Solid
Reconstitution Solubility: Soluble in DMSO (200 mg/mL), ethanol (100 mg/mL), Poorly soluble in water.
Handling Advice Protect from light and air.
Storage -20 °C
Expiry Date 24 months
Supplier Images
 image for Celecoxib (ABIN412149) Celecoxib
Product cited in: Obermajer, Wong, Edwards et al.: "Induction and stability of human Th17 cells require endogenous NOS2 and cGMP-dependent NO signaling." in: The Journal of experimental medicine, Vol. 210, Issue 7, pp. 1433-445, 2013 (PubMed).

Mao, Poschke, Wennerberg et al.: "Melanoma-educated CD14+ cells acquire a myeloid-derived suppressor cell phenotype through COX-2-dependent mechanisms." in: Cancer research, Vol. 73, Issue 13, pp. 3877-87, 2013 (PubMed).

Obermajer, Muthuswamy, Lesnock et al.: "Positive feedback between PGE2 and COX2 redirects the differentiation of human dendritic cells toward stable myeloid-derived suppressor cells." in: Blood, Vol. 118, Issue 20, pp. 5498-505, 2011 (PubMed).

Fujita, Kohanbash, Fellows-Mayle et al.: "COX-2 blockade suppresses gliomagenesis by inhibiting myeloid-derived suppressor cells." in: Cancer research, Vol. 71, Issue 7, pp. 2664-74, 2011 (PubMed).

Kwon, Lee, So et al.: "Generation of regulatory dendritic cells and CD4+Foxp3+ T cells by probiotics administration suppresses immune disorders." in: Proceedings of the National Academy of Sciences of the United States of America, Vol. 107, Issue 5, pp. 2159-64, 2010 (PubMed).

Catalog No. ABIN412149
Plus shipping costs $45.00

Order hotline:

  • +1 877 302 8632
  • +1 888 205 9894 (TF)